Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Lung Cancer
Interventions
DRUG

talabostat (PT-100) tablets

DRUG

Docetaxel

Trial Locations (10)

10029

Mt. Sinai School of Medicine, New York

10960

USB Cancer Center-- Nyack Hospital, Nyack

12208

New York Oncology/Hematology--Albany Regional Cancer Center, Albany

34761

Cancer Center of Florida, Ocoee

45409

Dayton Oncology & Hematology, Kettering

48236

Van Elslander Cancer Center, Grosse Pointe Woods

60637

University of Chicago, Chicago

75246

Mary Crowley Medical Research Center, Dallas

75702

Tyler Cancer Center, Tyler

99218

Cancer Care Northwest, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Point Therapeutics

INDUSTRY